1. Home
  2. SUPN vs STC Comparison

SUPN vs STC Comparison

Compare SUPN & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • STC
  • Stock Information
  • Founded
  • SUPN 2005
  • STC 1893
  • Country
  • SUPN United States
  • STC United States
  • Employees
  • SUPN N/A
  • STC N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • STC Specialty Insurers
  • Sector
  • SUPN Health Care
  • STC Finance
  • Exchange
  • SUPN Nasdaq
  • STC Nasdaq
  • Market Cap
  • SUPN 1.9B
  • STC 2.0B
  • IPO Year
  • SUPN 2012
  • STC N/A
  • Fundamental
  • Price
  • SUPN $34.09
  • STC $67.27
  • Analyst Decision
  • SUPN Hold
  • STC Buy
  • Analyst Count
  • SUPN 1
  • STC 3
  • Target Price
  • SUPN $36.00
  • STC $77.33
  • AVG Volume (30 Days)
  • SUPN 294.0K
  • STC 143.9K
  • Earning Date
  • SUPN 11-04-2024
  • STC 10-23-2024
  • Dividend Yield
  • SUPN N/A
  • STC 2.97%
  • EPS Growth
  • SUPN N/A
  • STC 66.11
  • EPS
  • SUPN 0.08
  • STC 2.12
  • Revenue
  • SUPN $630,163,000.00
  • STC $2,408,956,000.00
  • Revenue This Year
  • SUPN $4.01
  • STC N/A
  • Revenue Next Year
  • SUPN $0.10
  • STC $16.15
  • P/E Ratio
  • SUPN $357.31
  • STC $31.74
  • Revenue Growth
  • SUPN N/A
  • STC 3.20
  • 52 Week Low
  • SUPN $23.05
  • STC $44.05
  • 52 Week High
  • SUPN $35.56
  • STC $76.83
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 59.46
  • STC 40.24
  • Support Level
  • SUPN $33.73
  • STC $68.60
  • Resistance Level
  • SUPN $35.56
  • STC $70.36
  • Average True Range (ATR)
  • SUPN 0.79
  • STC 1.62
  • MACD
  • SUPN 0.05
  • STC -0.05
  • Stochastic Oscillator
  • SUPN 56.91
  • STC 4.43

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: